Cargando…
Systematic Review of Recurrent Osteosarcoma Systemic Therapy
SIMPLE SUMMARY: Osteosarcoma is the most common primary bone cancer. Its therapeutic approach includes cytotoxic chemotherapy and surgery. However, when recurrence or metastasis occurs the therapeutic options are limited with poor results. Herein we have conducted a systematic review of the systemic...
Autores principales: | Gazouli, Ioanna, Kyriazoglou, Anastasios, Kotsantis, Ioannis, Anastasiou, Maria, Pantazopoulos, Anastasios, Prevezanou, Maria, Chatzidakis, Ioannis, Kavourakis, Georgios, Economopoulou, Panagiota, Kontogeorgakos, Vasileios, Papagelopoulos, Panayiotis, Psyrri, Amanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067690/ https://www.ncbi.nlm.nih.gov/pubmed/33917001 http://dx.doi.org/10.3390/cancers13081757 |
Ejemplares similares
-
Tyrosine kinase inhibitors in sarcoma treatment
por: Kyriazoglou, Anastasios, et al.
Publicado: (2022) -
Immunotherapy in Nonendemic Nasopharyngeal Carcinoma: Real-World Data from Two Nonendemic Regions
por: Economopoulou, Panagiota, et al.
Publicado: (2021) -
Clinical Benefit of Pazopanib in a Patient with Metastatic Chondrosarcoma: A Case Report and Review of the Literature
por: Tsavaris, Onoufrios, et al.
Publicado: (2018) -
Real-World Data on Cabozantinib in Advanced Osteosarcoma and Ewing Sarcoma Patients: A Study from the Hellenic Group of Sarcoma and Rare Cancers
por: Kokkali, Stefania, et al.
Publicado: (2023) -
The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches
por: Economopoulou, Panagiota, et al.
Publicado: (2017)